This cohort study of older adults with type 2 diabetes examines the association of incident fracture with initiating a sodium-glucose cotransporter–2 inhibitor compared with initiating a dipeptidyl peptidase 4 inhibitor or a glucagon-like peptide 1 receptor agonist. Here, DPP4 is linked to type 2 diabetes mellitus.